OliX PharmaceuticalsInc (226950) — Cash Flow Quality Index
Latest as of December 2025:
-0.79x
OliX PharmaceuticalsInc (226950) has a Cash Flow Quality Index of -0.79x as of December 2025. Operating cash flow of ₩-12.16 Billion is below net income of ₩15.39 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore OliX PharmaceuticalsInc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.79x
Operating CF / Net Income
Operating Cash Flow
₩-12.16 Billion
KRW
Net Income
₩15.39 Billion
KRW
Data as of
Dec 2025
Most recent filing
Annual Cash Flow Quality Index for OliX PharmaceuticalsInc (None–None)
Year-by-year earnings quality comparison for OliX PharmaceuticalsInc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.